Estimation of prognosis of the individual with primary breast cancer and its applications

Scandinavian Journal of Surgery

Volumn 91, Issue 3, 2002, Pages 273-278

  Blamey, Roger W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; NPI; Predictive factors; Prognosis

Indexed keywords

BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; DISEASE COURSE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; PROGNOSIS; REVIEW;

EID: 0036409814     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690209100311     Document Type: Review

References (24)

1. Systemic Pathology 3rd Edition: The Breast. CW Elston & IO Ellis (Eds), Churchill Livingston, London. 1998
2. Blamey RW, Davies CJ, Elston CW, Johnson Jane, Haybittle JL, Maynard P: Prognostic factors in breast cancer - The formation of a prognostic index. Clin Oncol 1979;5:227-223
3. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987;56:489-492
4. Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT: The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res & Treat 1994;32(3):281-290
5. Sundquist M, Thorstenson S, Brudin L, Wingren S, Nordenskjold B: Incidence and prognosis in early onset breast cancer. Breast 2002;11:30-35
6. D'Eredita G, Martellotta M, Natale T, Ferrarese F: Prognostic factors in breast cancer: The predictive value of the Nottingham Prognostic Index in patients with a long term follow-up and treated in a single institution. Eur J Cancer 2001;37:591-596
7. Berstock DA, Houghton J, Haybittle J, Baum M: The role of radiotherapy following total mastectomy for patients with early breast cancer. World J Surg 1985;9:667-670
8. Morgan DAL, Berridge J, Blamey RW: Postoperative radio-therapy following mastectomy for high-risk breast cancer: A randomised trial. Eur J Cancer: 2002;38:1107-1110
9. Al-Hilaly M, Willsher PC, Robertson JFR, Blamey RW: Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer. Eur J Surg Oncol 1997;23:339-340
10. O'Rourke JS, Galea MH, Euhus D, Pinder S, Ellis IO, Elston CW, Blamey RW: An audit of local recurrence after simple mastectomy. Br J Surg 1994;81(3):386-389
11. Locker AP, Ellis IO, Morgan DAL, Mitchell A, Elston CW, Blamey RW: Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989;76:890-894
12. Macmillan RD, Purushotham AD, Connor AJM, Morgan DAL, Harnett AN, Locker AP, Malik HZ, Sibbering DM, Mallon EA, Elston CW, Ellis IO, Robertson JFR, George WD, Blamey RW: Local recurrence after breast-conserving surgery (BCS) - The Nottingham and Glasgow experience. Breast 1999;8:217 (Abstract)
13. Levi F, Lucchini F, Negri E, La Vecchia C: The decline in cancer mortality in the European Union, 1988-1996. Eur J Cancer 2000;36:1965-1968
14. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 1998;351:1451-1467
15. Maynard PV, Griffiths K, Davies CJ, Elston CW, Blamey RW: The relationships between oestrogen receptor content and histological grade in human primary breast tumours. Br J Cancer 1978;38:745
16. Bishop HM, Blamey RW, Morris AH, Rose DH, Preston B, Lane, Joyce, Doyle PJ: Bone scanning: Its lack of value in the follow-up of patients with breast cancer. Br J Surg 1979;66:752-754
17. Blamey RW and EUSOMA: Guidelines on endocrine therapy of breast cancer. Eur J Cancer 2002;38:615-634
18. Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes H, de Matteis A, Stewart A, Eiermann W, Szakolczai I, Palmer M, Schumacher M on behalf of the ZEBRA Trialists' Group: Goserelin vs CMF as adjuvant therapy in premenopausal patients with node-positive breast cancer: The ZEBRA study. J Clin Oncol 2002 - accepted for publication
19. Jakesz R, Hausmainger H, Samonigg H: Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer. Eur J Cancer 2002;38:327-332
20. Blamey RW, Chetty U, Mitchell A on behalf of the British Association of Surgeon Oncology (BASO) Breast Group: The BASO II trial of adjuvant radiotherapy .v. none and tamoxifen .v. none in small, node negative, grade 1 tumours. Eur J Cancer 2002;38:S149 (Abstract)
21. The Breast Screening Frequency Trial Group: The frequency of breast cancer screening: Results from the UKCCCR randomised trial. Eur J Cancer 2002;38:1458-1464
22. Cheung KL, Blamey RW, Robertson JFR, Elston CW, Ellis IO: Subcutaneous mastectomy for primary breast cancer and ductal carcinom in situ. Eur J Surg Oncol 1997;23:343-347
23. Pinder SE, Blamey RW, Evans AJ, Ellis IO, Lee AHSL, Elston CW: Lympho-vascular invasion (LVI) and prognosis in invasive breast cancer. Eur J Cancer 2002;38:S108 (Abstract)
24. Macmillan RD, Barbera D, Hadjiminas DJ, Rampaul RS, Lee AH, Pinder SE, Ellis IO, Blamey RW, Geraghty JG: Sentinel node biopsy for breast cancer may have little to offer four-node samplers: Results of a comparison study. Eur J Cancer 2001;37(9):1076-80